What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
Vitamin B12 supplementation during pregnancy for maternal and child health outcomes
Individuals with absorption issues, such as those with gastrointestinal disorders or certain genetic conditions, may not benefit from oral supplements
When levels drop below optimal ranges, the body signals distress through fatigue, weakness, and neurological complications
I have that much stuff going on the only time I find this stuff out is when I get referred to a consultant or have surgery
Your health takes priority over any awkwardness